FDA’s Message to Medical Device Company: Stop
By EsqSocial Corporation 29/11/13
The widely publicized start-up company 23andMe, Inc. markets its “personal genome service product” as providing reports on hundreds of diseases and conditions that enable users to “take steps toward mitigating serious diseases,” including diabetes,...
By: Venable LLP